Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone

Adult Cancer Pain

(2017) Robert Swarm et al.   Journal of the National Comprehensive Cancer Network

Laxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose

(2011) S. WIRZ et al.   EUROPEAN JOURNAL OF CANCER CARE

Methylnaltrexone and Gastrointestinal Perforation

(2010) Ann Corken Mackey et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Effect of Morphine Sulfate on Neonatal Neutrophil Chemotaxis

(2009) Panitan Yossuck et al.   CLINICAL JOURNAL OF PAIN

Quality of Life and Non-Pain Symptoms in Patients with Cancer

(2009) Marieke H.J. van den Beuken-van Everdingen et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation

(2009) A. M. Rentz et al.   JOURNAL OF MEDICAL ECONOMICS

Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study

(2008) Russell K. Portenoy et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor–induced angiogenesis

(2008) Patrick A. Singleton et al.   MOLECULAR CANCER THERAPEUTICS

Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness

(2008) Jay Thomas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer Immunology

(2008) Olivera J. Finn   NEW ENGLAND JOURNAL OF MEDICINE